> top > projects > sentences > docs > PubMed:23019155 > annotations
sentences Home  

PubMed:23019155 JSONTXT 63 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-80 Sentence denotes Investigation of the substrate specificity of K5 lyase A from K5A bacteriophage.
T1 0-80 Sentence denotes Investigation of the substrate specificity of K5 lyase A from K5A bacteriophage.
T1 0-80 Sentence denotes Investigation of the substrate specificity of K5 lyase A from K5A bacteriophage.
TextSentencer_T2 81-236 Sentence denotes K5 lyase A (KflA) is a tailspike protein from the K5A phage that catalyzes the degradation of the capsule polysaccharide of K5 strains of Escherichia coli.
T2 81-236 Sentence denotes K5 lyase A (KflA) is a tailspike protein from the K5A phage that catalyzes the degradation of the capsule polysaccharide of K5 strains of Escherichia coli.
T2 81-236 Sentence denotes K5 lyase A (KflA) is a tailspike protein from the K5A phage that catalyzes the degradation of the capsule polysaccharide of K5 strains of Escherichia coli.
TextSentencer_T3 237-469 Sentence denotes The K5 E. coli capsule polysaccharide, also known as heparosan, is composed of the disaccharide repeating unit of [-4)-GlcA-β(1,4)-GlcNAc-α(1-] and therefore identical to the biological precursor of heparin and heparan sulfate (HS).
T3 237-469 Sentence denotes The K5 E. coli capsule polysaccharide, also known as heparosan, is composed of the disaccharide repeating unit of [-4)-GlcA-β(1,4)-GlcNAc-α(1-] and therefore identical to the biological precursor of heparin and heparan sulfate (HS).
T3 237-469 Sentence denotes The K5 E. coli capsule polysaccharide, also known as heparosan, is composed of the disaccharide repeating unit of [-4)-GlcA-β(1,4)-GlcNAc-α(1-] and therefore identical to the biological precursor of heparin and heparan sulfate (HS).
TextSentencer_T4 470-539 Sentence denotes KflA could supplement the heparin lyases for heparin and HS analysis.
T4 470-539 Sentence denotes KflA could supplement the heparin lyases for heparin and HS analysis.
T4 470-539 Sentence denotes KflA could supplement the heparin lyases for heparin and HS analysis.
TextSentencer_T5 540-692 Sentence denotes The first part of this study aimed to clarify ambiguity resulting from the revision of the KflA amino acid sequence in 2010 from that published in 2000.
T5 540-692 Sentence denotes The first part of this study aimed to clarify ambiguity resulting from the revision of the KflA amino acid sequence in 2010 from that published in 2000.
T5 540-692 Sentence denotes The first part of this study aimed to clarify ambiguity resulting from the revision of the KflA amino acid sequence in 2010 from that published in 2000.
TextSentencer_T6 693-864 Sentence denotes We found that only the expression of the updated sequence gave a soluble active enzyme, which produced heparosan degradation products similar to those of previous studies.
T6 693-864 Sentence denotes We found that only the expression of the updated sequence gave a soluble active enzyme, which produced heparosan degradation products similar to those of previous studies.
T6 693-864 Sentence denotes We found that only the expression of the updated sequence gave a soluble active enzyme, which produced heparosan degradation products similar to those of previous studies.
TextSentencer_T7 865-1022 Sentence denotes Next, we examined the specificity of KflA toward heparosan oligosaccharides of varying sizes, all containing a single N-sulfated glucosamine (GlcNS) residue.
T7 865-1022 Sentence denotes Next, we examined the specificity of KflA toward heparosan oligosaccharides of varying sizes, all containing a single N-sulfated glucosamine (GlcNS) residue.
T7 865-1022 Sentence denotes Next, we examined the specificity of KflA toward heparosan oligosaccharides of varying sizes, all containing a single N-sulfated glucosamine (GlcNS) residue.
TextSentencer_T8 1023-1177 Sentence denotes The presence of GlcNS in an octasaccharide and a nonasaccharide chain directed cleavage by KflA to a single position at the reducing end of the substrate.
T8 1023-1177 Sentence denotes The presence of GlcNS in an octasaccharide and a nonasaccharide chain directed cleavage by KflA to a single position at the reducing end of the substrate.
T8 1023-1177 Sentence denotes The presence of GlcNS in an octasaccharide and a nonasaccharide chain directed cleavage by KflA to a single position at the reducing end of the substrate.
TextSentencer_T9 1178-1382 Sentence denotes However, an N-sulfated decasaccharide exhibited extensive cleavage at the nonreducing end of the chain, illustrating a distinct change in the cleavage pattern of KflA toward substrates of differing sizes.
T9 1178-1382 Sentence denotes However, an N-sulfated decasaccharide exhibited extensive cleavage at the nonreducing end of the chain, illustrating a distinct change in the cleavage pattern of KflA toward substrates of differing sizes.
T9 1178-1382 Sentence denotes However, an N-sulfated decasaccharide exhibited extensive cleavage at the nonreducing end of the chain, illustrating a distinct change in the cleavage pattern of KflA toward substrates of differing sizes.
TextSentencer_T10 1383-1539 Sentence denotes Because KflA is able to cleave a substrate containing isolated GlcNS residues, this enzyme could be used for the analysis of low-sulfate content HS domains.
T10 1383-1539 Sentence denotes Because KflA is able to cleave a substrate containing isolated GlcNS residues, this enzyme could be used for the analysis of low-sulfate content HS domains.
T10 1383-1539 Sentence denotes Because KflA is able to cleave a substrate containing isolated GlcNS residues, this enzyme could be used for the analysis of low-sulfate content HS domains.